Compare LNSR & MSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LNSR | MSD |
|---|---|---|
| Founded | 2004 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Electronics | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.8M | 151.1M |
| IPO Year | N/A | N/A |
| Metric | LNSR | MSD |
|---|---|---|
| Price | $12.56 | $7.59 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 30.5K | ★ 70.2K |
| Earning Date | 02-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.26% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $59,141,000.00 | N/A |
| Revenue This Year | $19.55 | N/A |
| Revenue Next Year | $35.89 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 21.02 | N/A |
| 52 Week Low | $8.25 | $6.11 |
| 52 Week High | $17.31 | $7.46 |
| Indicator | LNSR | MSD |
|---|---|---|
| Relative Strength Index (RSI) | 68.69 | 65.51 |
| Support Level | $11.86 | $7.44 |
| Resistance Level | $12.09 | $7.52 |
| Average True Range (ATR) | 0.31 | 0.06 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 99.61 | 94.23 |
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.
Morgan Stanley Emerg Mkts Debt Fd Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to produce high current income and as a secondary objective to seek capital appreciation, through investments mainly in debt securities of government and government-related issuers located in emerging countries, of entities organized to restructure the outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries.